5-HTP 관련 수면 개시 장애
D7건의 연구에 근거합니다. 7건 중 7건의 연구에서 긍정적인 효과가 나타났습니다.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'sleepcited.com';
const params = 'ingredient\u003D5\u002Dhtp\u0026condition\u003Dsleep\u002Donset\u002Dlatency';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
D
결론
There is not yet enough human research to confirm that 5-HTP helps you fall asleep faster, though early animal research is encouraging.
- All 7 studies are animal or preclinical studies with no human trial data
- Evidence grade is D, indicating very limited evidence
- 5-HTP works through the serotonin system, which plays a role in sleep onset
- Human clinical trials are needed before recommendations can be made
Key Study Findings
Animal study
Ginsenoside Rg1 alleviates PCPA-induced insomnia by inhibiting NLRP3 inflammasome activation and pyroptosis through the Nrf2/HO-1 …
Dose: None
vs: Placebo
효과: None
None
Animal Study
Promotion of sleep by cinnamic acid in parachlorophenylalanine-induced insomnia in rats.
Dose: Cinnamic acid (CA) administered to rats (dose not specified)
vs: Placebo
효과: None
None
animal study (preclinical)
Study on the hypnotic effect of rare protopanaxadiol-type and protopanaxatriol-type ginsenosides.
Dose: up to 96 mg/kg
vs: Placebo
효과: None
None
animal study (preclinical)
Two combined amino acids promote sleep activity in caffeine-induced sleepless model systems.
Dose: not fully specified (dose ranges tested in Drosophila, ICR mice, and SD rats)
vs: Placebo
효과: None
p < 0.001 (combined GABA/5-HTP
animal study (preclinical)
Flos Albiziae aqueous extract and its active constituent quercetin potentiate the hypnotic effect of pentobarbital …
Dose: various doses; pentobarbital 50 mg/kg (full dose) or 28 mg/kg (sub-hypnotic dose) IP
vs: Placebo
효과: None
None
In Vitro
Pharmacological evaluation of sedative and hypnotic effects of schizandrin through the modification of pentobarbital-induced sleep …
Dose: 5-45 mg/kg i.p. schizandrin
vs: Placebo
효과: Dose-dependent decrease in sleep latency and increase in sleep duration
None
Key Statistics
7
연구
--
참여자
↑
Positive
D
등급
Referenced Papers
Psychopharmacology
2025
5 인용
International immunopharmacology
2025
1 인용
Study on the hypnotic effect of rare protopanaxadiol-type and protopanaxatriol-type ginsenosides.
Other
RSC advances
2019
13 인용
Nutrition research and …
2018
12 인용
Biomedical reports
2015
12 인용
European journal of …
2014
43 인용
Pharmacology, biochemistry, and …
2008
76 인용
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
일반적으로 사용되는 용량
- sleep:
- 100-300 mg, 30-45 min before bed
상한량: Not established; serotonin syndrome risk with SSRIs
연구에서 사용된 용량
| 용량 | 기간 | 효과 | N |
|---|---|---|---|
| None | -- | Positive | -- |
| Cinnamic acid (CA) administered to rats (dose not specified) | -- | Positive | -- |
| up to 96 mg/kg | -- | Positive | -- |
| not fully specified (dose ranges tested in Drosophila, ICR mice, and SD rats) | -- | Positive | -- |
| various doses; pentobarbital 50 mg/kg (full dose) or 28 mg/kg (sub-hypnotic dose) IP | -- | Positive | -- |
| 5-45 mg/kg i.p. schizandrin | -- | Positive | -- |
| Spinosin various doses; pentobarbital 45 mg/kg or 28 mg/kg i.p.; 5-HTP 2.5 mg/kg i.p.; PCPA 300 mg/k | -- | Positive | -- |
권장 복용 시간: 30-45 minutes before bed
Safety & Side Effects
보고된 부작용
- ⚠ Nausea
- ⚠ Diarrhea
- ⚠ Heartburn
- ⚠ Stomach pain
- ⚠ Drowsiness
알려진 상호작용
- ● SSRIs/SNRIs — serious risk of serotonin syndrome
- ● MAOIs — dangerous serotonin accumulation
- ● Tramadol — increased serotonin syndrome risk
- ● Carbidopa — may cause scleroderma-like skin changes
일일 최대 섭취 허용량: Not established; serotonin syndrome risk with SSRIs
건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.
Frequently Asked Questions
Does 5-HTP help with 수면 개시 장애?
Based on 7 studies with 0 participants, there is preliminary evidence that needs more research that 5-HTP may support 수면 개시 장애 management. Our evidence grade is D (Very Early Research).
How much 5-HTP should I take for 수면 개시 장애?
Studies have used various dosages. A commonly studied range is 100-300 mg, 30-45 min before bed. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of 5-HTP?
Reported side effects may include Nausea, Diarrhea, Heartburn, Stomach pain. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for 5-HTP and 수면 개시 장애?
We rate the evidence as Grade D (Very Early Research). This rating is based on 7 peer-reviewed studies with 0 total participants. The overall direction of effect is positive.
Related Evidence
FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.